RxDoctor Payments Data

Ashley Wilson

Physician Assistant · Myrtle Beach, SCNPI 1487655106

Payments from drug & device makers

$5,885in general payments, 2019–2025

Across 362 payments — averaging $16.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$800
  • AbbVie$737
  • Johnson & Johnson$692
  • Novo Nordisk$516
  • UCB, Inc.$375
  • Antares Pharma, Inc.$321
  • plus $2K from 40 others

What the payments were for

  • Food & beverage$5,83699%
  • Education$491%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,885 in reported general payments places this provider in the 90th percentile of 1,852 physician assistant providers in South Carolina.

See all physician assistant providers in South Carolina

Medicare billing

Part B allowed, 2024
$86,251
Medicare patients
305
Services billed
1,882

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide84$129,448
MounjaroTirzepatide87$106,964
FarxigaDapagliflozin Propanediol99$104,833
EliquisApixaban81$82,353
TrulicityDulaglutide38$47,980
JardianceEmpagliflozin32$42,488
XareltoRivaroxaban26$39,546
Trelegy ElliptaFluticasone/Umeclidin/Vilanter23$25,152
LinzessLinaclotide28$24,969
MyrbetriqMirabegron23$23,623
JanuviaSitagliptin Phosphate24$22,527
Repatha SureclickEvolocumab16$16,476
Soliqua 100-33Insulin Glargine/Lixisenatide19$16,359
Breztri AerosphereBudesonide/Glycopyr/Formoterol20$14,992
Dexlansoprazole DrDexlansoprazole30$7,470

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$37$154,944125 claims
Novo NordiskOzempic$516$129,44884 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$227$126,069135 claims
PfizerEliquis$65$82,35381 claims
Boehringer IngelheimJardiance$14$42,48832 claims
Johnson & JohnsonXarelto$692$39,54626 claims
AbbVieLinzess, Synthroid$737$31,827108 claims
GSKTrelegy Ellipta$70$25,15223 claims
Astellas Pharma US IncMyrbetriq$33$23,62323 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$146$16,35919 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$56$7,21015 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,852 physician assistant providers in South Carolina.

Other physician assistant in Myrtle Beach

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →